亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Integrative Leakage Correction For Contrast Agent Extravasation In Dynamic Susceptibility Contrast (DSC) - MRI

技術優勢
Estimates rCBV, blood flow, and other perfusion parameters with higher accuracy  Simultaneously provides additional information about vascular permeability, normally collected using dynamic contrast enhanced (DCE) MRI, with only one injection Reduces variability across different MRI systems or acquisition parameters
技術應用
Dynamic susceptibility contrast (DSC) perfusion MRI  Dynamic computed tomography (CT) perfusion imaging  Brain tumor imaging  Stroke and ischemic disease  Traumatic brain injury (TBI)
詳細技術說明
UCLA researchers have developed an improved model for correcting DSC perfusion MRI contrast leakage. By performing compartmental modeling of contrast agent flux into and out of the vasculature, they demonstrate higher accuracy calculations of relative cerebral volume (rCBV), a parameter often used for clinical management of patients with a variety of neurological disorders. This method can simultaneously calculate dynamic contrast enhanced (DCE)- MRI physiological parameters, such as vascular permeability, without a 2nd injection or additional MRI scans. Therefore, this model gains DSC-MRI and DCE-MRI information from only one injection/measurement. Additionally, this method has been shown to lower the variability of perfusion parameter estimations that exists due to differences in the MRI system hardware, software, and acquisition strategies or parameters.
*Abstract
UCLA researchers in the Department of Radiological Sciences have developed a new technique for more accurately estimating relative cerebral blood volume (rCBV) from dynamic susceptibility contrast (DSC) perfusion MRI by improved modeling and correction of contrast agent leakage.
*Principal Investigation

Name: Benjamin Ellingson

Department:


Name: Kevin Leu

Department:

其他

State Of Development

  • Stand-alone prototype application for Mac 
  • Prototype source code in Matlab 
  • Variety of institutions and companies are currently evaluating the prototype

Background

Dynamic susceptibility contrast (DSC) perfusion MRI scans are routinely collected on brain tumors, stroke, and traumatic brain injury patients, but accurate estimation of perfusion parameters is confounded due to contrast agent leakage into tissues as a result of changes in blood-brain barrier permeability. Companies such as IB Neuro, Olea Medical, NordicICE, General Electric, and Siemens currently employ a simple leakage correction technique to overcome these challenges. However, the commonly employed contrast agent leakage correction method does not properly correct for contrast agent exchange with surrounding tissues. Therefore, there is need for a better method that more properly corrects for contrast agent leakage in order to improve estimation of perfusion parameters.


Related Materials

Leu, K., Boxerman, J.L., and Ellingson, B.M. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas, American Journal of Neuroradiology, 2017.
Leu, K., Boxerman, J.L., Cloughesy, T.F., Lai, A., Nghiemphu, P.L., Liau, L.M., Pope, W.B., and Ellingson, B.M., Improved leakage correction for single-echo dynamic susceptibility contrast perfusion MRI estimates of relative cerebral blood volume in high-grade gliomas by accounting for bidirectional contrast agent exchange, American Journal of Neuroradiology, 2016.
Leu, K., Boxerman, J.L., Lai, A., Nghiemphu, P.L., Pope, W.B., Cloughesy, T.F., and Ellingson, B.M., Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab, Journal of Magnetic Resonance Imaging, 2016.


Additional Technologies by these Inventors


Tech ID/UC Case

29465/2015-089-0


Related Cases

2015-089-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備